NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.

Moderna Covid vaccine approved for those 12-64 with risk factors Moderna expects mNEXSPIKE to be ready for 2025-2026 season ...

The shot is also cleared for individuals between 12 and 64 years of age who are at least one risk factor as defined by the ...

The US FDA has approved Moderna's new COVID-19 vaccine, mNEXSPIKE, amidst emerging coronavirus variants. It is approved for ...

The US FDA has approved Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, for use in adults aged 65 and older.

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...

Here’s everything parents should know about the COVID-19 vaccines for pregnant women, including why it's still an important way to protect yourself and your baby. Should I get t ...

The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...

The US government has canceled a $600 million contract with Moderna to develop a vaccine for bird flu and other dangerous flu strains.

With the continued use of COVID-19 vaccines worldwide, there’s a massive amount of data that shows mRNA shots are safe.

With COVID cases rising in India and several other countries, many people are wondering whether they should get vaccinated.